Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
May 30, 2024 16:51 ET
|
Biogen Inc.
SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in Europe1QALSODY is Biogen’s third rare disease therapy to be approved in the...
BurgerFi to Consider Strategic Alternatives
May 30, 2024 16:51 ET
|
BurgerFi International
Designates David Heidecorn as successor to Ophir Sternberg as Chairman of the Board Enters retention agreements with executive leadership to ensure steady leadership FORT LAUDERDALE,...
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
May 30, 2024 16:47 ET
|
OncoCyte Corporation
Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...
SAB Biotherapeutics Announces Departure of Chief Financial Officer
May 30, 2024 16:45 ET
|
SAB Biotherapeutics, Inc.
MIAMI, May 30, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
May 30, 2024 16:44 ET
|
Pharming Group N.V.
Leiden, the Netherlands, May 30, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today an update on the ongoing review of its Marketing...
DBV Technologies participera au prochain congrès EAACI 2024
May 30, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, le 30 mai (22h30 CEST) 2024 DBV Technologies participera au prochain congrès EAACI 2024 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une...
Dyadic to Attend Industry Events in June
May 30, 2024 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of...
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 16:30 ET
|
Dianthus Therapeutics, Inc.
NEW YORK and WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of...
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
May 30, 2024 16:30 ET
|
Verrica Pharmaceuticals Inc.
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin...
LanzaTech Names Head of Investor Relations
May 30, 2024 16:30 ET
|
LanzaTech Inc.
CHICAGO, May 30, 2024 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), the carbon recycling company transforming waste carbon into sustainable raw materials,...